Literature DB >> 31351820

Carbapenem-resistant Acinetobacter baumannii in patients with burn injury: A systematic review and meta-analysis.

William Gustavo Lima1, Geisa Cristina Silva Alves2, Cristina Sanches2, Simone Odília Antunes Fernandes3, Magna Cristina de Paiva4.   

Abstract

PURPOSE: In this study, we aimed reviewed the data about the patterns of antimicrobial susceptibility and resistance determinants among carbapenem-resistant Acinetobacter baumannii (CRAB) from patients with burn injury.
METHODS: A systematic review was conducted using the PRISMA statement in PUBMED/MEDLINE, Scopus, Scientific Electronic Library Online (SciELO), Biblioteca Virtual de Saúde (BVS) and Cochrane Library. The data referring to enzymatic resistance mechanisms were evaluated by meta-analyses according to random effect.
RESULTS: 17 articles that evaluated 1226 CRAB recovered from patients with burn injury were included in study. The majority of studies are from Iran (12/17; 70.6%), published in 2016 (6/17; 35.3%) and showed prospective design (15/17; 88.2%). The samples were obtained mainly from burn wounds (14/17; 82.3%) and more than half of the studies did not identify if the isolates originated from infected or colonized patients (10/17; 58.8%). Second the meta-analyses, OXA-type carbapenemase was the main mechanism involved in low susceptibility to carbapenems (53.2%; 95% CI = 60, 80.0%, I2 = 86.0%), followed by metallo-β-lactamases (MBL) (30.2%; 95% CI = 11, 42.0%, I2 = 93.0%), and Klebsiella pneumoniae carbapenemase (KPC) (16.6%; 95% CI = 5, 63.0%, I2 = 88.0%). The majority of strains harbored blaOXA-23-like (12/17; 70.6%) or blaOXA-24/40-like (12/17; 35.3%) genes. The studies included showed that minocycline (69.5%) and colistin (99.9%) susceptibility remains high and is not impacted by carbapenem resistance in these isolates.
CONCLUSIONS: The results summarized in this review indicate the importance of a high-quality surveillance program to design suitable and effective interventions to control CRAB infection in burn units worldwide. Published by Elsevier Ltd.

Entities:  

Keywords:  Acinetobacter baumannii; Burn units; Colistin; Healthcare-associated infections; Minocycline; Multi-drug resistance

Mesh:

Substances:

Year:  2019        PMID: 31351820     DOI: 10.1016/j.burns.2019.07.006

Source DB:  PubMed          Journal:  Burns        ISSN: 0305-4179            Impact factor:   2.744


  8 in total

1.  A short synthetic peptide, based on LyeTx I from Lycosa erythrognatha venom, shows potential to treat pneumonia caused by carbapenem-resistant Acinetobacter baumannii without detectable resistance.

Authors:  William Gustavo Lima; Júlio César Moreira Brito; Maria Elena de Lima; Amanda Cristina Silva Tardelli Pizarro; Maria Auxiliadora Martins de Mello Vianna; Magna Cristina de Paiva; Débora Cristina Sampaio de Assis; Valbert Nascimento Cardoso; Simone Odília Antunes Fernandes
Journal:  J Antibiot (Tokyo)       Date:  2021-05-10       Impact factor: 2.649

2.  Molecular Epidemiology of Carbapenem-Resistant Acinetobacter baumannii in the United States, 2013-2017.

Authors:  Susannah L McKay; Nicholas Vlachos; Jonathan B Daniels; Valerie S Albrecht; Valerie A Stevens; J Kamile Rasheed; J Kristie Johnson; Joseph D Lutgring; Maria Sjölund-Karlsson; Alison Laufer Halpin
Journal:  Microb Drug Resist       Date:  2022-05-27       Impact factor: 2.706

3.  Comparative analysis of carbapenemases, RND family efflux pumps and biofilm formation potential among Acinetobacter baumannii strains with different carbapenem susceptibility.

Authors:  Yanpeng Zhang; Bing Fan; Yong Luo; Zhiyuan Tao; Yongbo Nie; Yongtao Wang; Fanglin Ding; Yanwu Li; Dayong Gu
Journal:  BMC Infect Dis       Date:  2021-08-20       Impact factor: 3.090

4.  Colistin Therapy, Survival and Renal Replacement Therapy in Burn Patients: A 10-Year Single-Center Cohort Study.

Authors:  Filippo Mariano; Valeria Malvasio; Daniela Risso; Nadia Depetris; Anna Pensa; Giacomo Fucale; Fabrizio Gennari; Luigi Biancone; Maurizio Stella
Journal:  Int J Gen Med       Date:  2022-05-25

Review 5.  Effectiveness of supplementation with quercetin-type flavonols for treatment of viral lower respiratory tract infections: Systematic review and meta-analysis of preclinical studies.

Authors:  Júlio César Moreira Brito; William Gustavo Lima; Lídia Pereira B Cordeiro; Waleska Stephanie da Cruz Nizer
Journal:  Phytother Res       Date:  2021-04-17       Impact factor: 6.388

Review 6.  Carbapenemases: Transforming Acinetobacter baumannii into a Yet More Dangerous Menace.

Authors:  Maria Soledad Ramirez; Robert A Bonomo; Marcelo E Tolmasky
Journal:  Biomolecules       Date:  2020-05-06

7.  Nosocomial transmission of extensively drug resistant Acinetobacter baumannii strains in a tertiary level hospital.

Authors:  Paúl Alexis López-Durán; Salvador Fonseca-Coronado; Lucila Maritza Lozano-Trenado; Sergio Araujo-Betanzos; Deniria Alejandra Rugerio-Trujillo; Gilberto Vaughan; Elsa Saldaña-Rivera
Journal:  PLoS One       Date:  2020-04-17       Impact factor: 3.240

8.  Isolation, characterization, and effectiveness of bacteriophage Pɸ-Bw-Ab against XDR Acinetobacter baumannii isolated from nosocomial burn wound infection.

Authors:  Ladan Rahimzadeh Torabi; Monir Doudi; Nafiseh Sadat Naghavi; Ramesh Monajemi
Journal:  Iran J Basic Med Sci       Date:  2021-09       Impact factor: 2.699

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.